The growing complexity of drug development is encouraging pharmaceutical companies to collaborate with specialized CROs. External research providers can offer multidisciplinary expertise across pharmacology, toxicology, bioanalysis, and disease-model development, supporting more comprehensive preclinical programs. The Preclinical CROs Market is expanding as pharmaceutical and biotechnology...